Imagine getting a definitive test result for a serious infection in fifteen minutes while still sitting in your doctor's office — instead of waiting three days for a lab report. Or having a nurse check your cardiac biomarkers bedside in an emergency room without sending blood to a central lab. Or testing for a sexually transmitted infection at a community pharmacy and getting your result before you leave the building. All of this is already happening, and it's only getting better. The point of care diagnostics and testing market has fundamentally shifted how and where healthcare decisions get made, and the market is reflecting that shift with remarkable growth.

Point of care (POC) testing refers to diagnostic testing performed at or near the patient — in clinics, emergency departments, pharmacies, homes, or even in the field — rather than in centralised hospital or reference laboratories. The advantages are obvious: faster results, faster treatment decisions, better patient flow, and reduced burden on centralised lab infrastructure. The COVID-19 pandemic dramatically accelerated POC adoption, as rapid antigen tests became a global public health tool practically overnight. But the broader POC market had been growing strongly for years before COVID and is projected to continue growing even faster in its wake. This point of care diagnostics market size and growth forecast provides a comprehensive view of current market dynamics and projections through 2035.

The technology driving POC diagnostics is genuinely impressive. Microfluidic lab-on-a-chip devices can perform complex multi-parameter tests on tiny samples in minutes. Biosensor platforms are achieving sensitivity levels that rival central lab equipment but in formats small enough to fit on a countertop. Smartphone-integrated diagnostic devices are enabling testing in low-resource settings that would previously have been impossible. And AI-powered interpretation of POC test results is reducing the risk of user error, which has historically been a concern with tests run outside of laboratory settings.

The point of care diagnostics industry is also being driven by a broader shift in healthcare philosophy — from reactive, hospital-centric care to proactive, decentralised, patient-centred care. POC testing is a critical enabler of that shift, allowing early detection, rapid response, and ongoing monitoring of chronic conditions outside of traditional healthcare settings. It's hard to overstate how fundamentally this is reshaping the way healthcare works, and the market numbers reflect the scale of that transformation.